ReviewGastro hep advances2026

CYP2D6 Metabolizer Status Does Not Predict Response or Tolerability of Low-Dose Nortriptyline for Irritable Bowel Syndrome With Diarrhea.

Kyle Staller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.